Partnership Opportunities

Discover Exclusive Partnership Opportunities at the 4th LNP Immunogenicity & Toxicity Summit:

The 4th LNP Immunogenicity & Toxicity Digital Summit stands as the only forum uniting an international community of 80+ scientific leaders, biotech pioneers, and regulatory experts to tackle the critical challenges of lipid nanoparticle safety and immune response.

Providing you with global insights and connections from the comfort of your office, the program includes cutting-edge data and networking opportunities with AstraZeneca, Pfizer, Bayer, Sanofi and more, seeking to advance their scientific understanding and drive the next-generation of LNP therapies with partners like you.

Get in touch today to discover how partnering with this unique platform can help elevate your brand at the intersection of innovation, collaboration, and therapeutic LNP impact.

Industry Experts Need Your Help With:

https://lnp-immunogenicity-toxicity-summit.com/wp-content/uploads/sites/813/2022/08/cropped-HW220702-LNP-Immunogenicity-and-Toxicity-logo-Favicon.png

Bioanalytical: Immunogenicity Screening & Assays

Biotechs urgently need partners who can uncover hidden immune risks early. With regulators demanding stronger safety packages, innovative assay providers are essential to de-risk development and accelerate breakthroughs

https://lnp-immunogenicity-toxicity-summit.com/wp-content/uploads/sites/813/2022/08/cropped-HW220702-LNP-Immunogenicity-and-Toxicity-logo-Favicon.png

CRO: Tox/PKPD Testing

The pressure to prove safety faster has never been higher. Biopharma is turning to CROs for cutting-edge toxicity and PK/PD studies that deliver the insights needed to unlock funding and move programs forward 

https://lnp-immunogenicity-toxicity-summit.com/wp-content/uploads/sites/813/2022/08/cropped-HW220702-LNP-Immunogenicity-and-Toxicity-logo-Favicon.png

Models: In Vivo & In Vitro

Traditional models often fail to predict clinical outcomes. That’s why biopharma is in need of innovators in advanced in vivo and in vitro systems who can bring speed, accuracy, and translational power to drug discovery 

https://lnp-immunogenicity-toxicity-summit.com/wp-content/uploads/sites/813/2022/08/cropped-HW220702-LNP-Immunogenicity-and-Toxicity-logo-Favicon.png

Delivery Technology Companies

The future of LNP therapies depends on smarter delivery. Industry experts are searching for partners with novel LNP platforms that can overcome stability, targeting, and scalability challenges to make these therapies a reality. 

Why Partner?

Be at the Center of Breakthrough Science 

This is the only dedicated forum focused on overcoming LNP immunogenicity and toxicity challenges. With cutting-edge discussions on degradable LNPs, AI-driven design, and translational safety models, partners align their brand with the forefront of therapeutic innovation

Access Decision-Makers Driving Next-Generation Therapies

Position yourself in front of front of the leaders shaping clinical success in RNA, gene, and vaccine delivery with an engaged audience working in LNP immunology, toxicology, pharmacology, and bioanalytics 

Showcase Solutions to a Market in Urgent Need 

Highlight your capabilities as the trusted solution-provider in a time when biopharma actively seeking novel assays, models, CRO support, and delivery technologies to overcome safety hurdles

Who You Could Connect With:

LNP Immunogenicity & Toxicity Summit

Get In Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Nicholas

Nick Ramovic
Partnerships Director